Jacobson Pharma Corporation Limited (HKG:2633)

Hong Kong · Delayed Price · Currency is HKD

1.070

0.00 (0.00%)

Jul 31, 2026, 3:57 PM HKT

-36.69% (1Y)

Market Cap	2.14B -36.5%
Revenue (ttm)	1.57B -0.5%
Net Income	301.62M +0.3%
EPS	0.15 -0.3%
Shares Out	2.00B
PE Ratio	7.09
Forward PE	6.77
Dividend	0.09 (8.41%)
Ex-Dividend Date	Sep 7, 2026

Volume	12,000
Open	1.070
Previous Close	1.070
Day's Range	1.070 - 1.070
52-Week Range	0.980 - 1.690
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About HKG:2633

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare. The company offers generic drugs for various therapeutic categories, including cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergic. It... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2016

Employees 1,768

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2633

Full Company Profile

Financial Performance

In fiscal year 2026, HKG:2633's revenue was 1.57 billion, a decrease of -0.47% compared to the previous year's 1.58 billion. Earnings were 301.62 million, an increase of 0.26%.

Financial Statements